Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Lung Cancer

  Free Subscription


Articles published in Thorax

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    November 2020
  1. CARTER-HARRIS L
    Hidden in plain sight: psychological barriers to participation in lung cancer screening.
    Thorax. 2020 Nov 2. pii: thoraxjnl-2020-216191.
    PubMed    


    October 2020
  2. KUMMER S, Waller J, Ruparel M, Duffy SW, et al
    Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
    Thorax. 2020 Oct 21. pii: thoraxjnl-2020-215054.
    PubMed     Abstract available


  3. FIELD JK, Vulkan D, Davies MPA, Duffy SW, et al
    Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation.
    Thorax. 2020 Oct 20. pii: thoraxjnl-2020-215158.
    PubMed     Abstract available


  4. FREISLING H, Seyed Khoei N, Viallon V, Wagner KH, et al
    Gilbert's syndrome, circulating bilirubin and lung cancer: a genetic advantage?
    Thorax. 2020 Oct 6. pii: thoraxjnl-2020-215642.
    PubMed    


    September 2020
  5. FARAHI N, Gillett D, Southwood M, Rassl D, et al
    Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CT.
    Thorax. 2020 Sep 4. pii: thoraxjnl-2020-214642.
    PubMed     Abstract available


    August 2020
  6. HORSFALL LJ, Burgess S, Hall I, Nazareth I, et al
    Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank.
    Thorax. 2020 Aug 27. pii: thoraxjnl-2020-214756.
    PubMed     Abstract available


  7. HORST C, Dickson JL, Tisi S, Ruparel M, et al
    Delivering low-dose CT screening for lung cancer: a pragmatic approach.
    Thorax. 2020 Aug 13. pii: thoraxjnl-2020-215131.
    PubMed    


  8. RUPAREL M, Quaife SL, Dickson JL, Horst C, et al
    Lung Screen Uptake Trial: results from a single lung cancer screening round.
    Thorax. 2020 Aug 5. pii: thoraxjnl-2020-214703.
    PubMed     Abstract available


    July 2020
  9. BALDWIN D, O'Dowd E, Ten Haaf K
    Targeted screening for lung cancer is here but who do we target and how?
    Thorax. 2020 Jul 6. pii: thoraxjnl-2020-215156.
    PubMed    


  10. LEBRETT MB, Balata H, Evison M, Colligan D, et al
    Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme.
    Thorax. 2020 Jul 6. pii: thoraxjnl-2020-214626.
    PubMed     Abstract available


    June 2020
  11. SACHS E, Jackson V, Sartipy U
    Household disposable income and long-term survival after pulmonary resections for lung cancer.
    Thorax. 2020 Jun 20. pii: thoraxjnl-2019-214321.
    PubMed     Abstract available


    May 2020
  12. BALATA H, Harvey J, Barber PV, Colligan D, et al
    Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Thorax. 2020 May 22. pii: thoraxjnl-2019-213584.
    PubMed     Abstract available


  13. CRAWLEY D, Breen RA, Elkington PT, Karapanagiotou E, et al
    Tuberculosis associated with Triplet therapy for lung cancer.
    Thorax. 2020 May 14. pii: thoraxjnl-2019-213913.
    PubMed     Abstract available


    April 2020
  14. PARK HY, Kang D, Shin SH, Yoo KH, et al
    Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.
    Thorax. 2020 Apr 2. pii: thoraxjnl-2019-213732.
    PubMed     Abstract available


  15. BALDWIN DR, Gustafson J, Pickup L, Arteta C, et al
    External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules.
    Thorax. 2020;75:306-312.
    PubMed     Abstract available


    March 2020
  16. GROVER H, Ross T, Fuller E
    Implementation of targeted screening for lung cancer in a high-risk population within routine NHS practice using low-dose computed tomography.
    Thorax. 2020 Mar 3. pii: thoraxjnl-2019-214303.
    PubMed     Abstract available


    January 2020
  17. HILEY C, Salem A, Batchelor T, McDonald F, et al
    Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer.
    Thorax. 2020 Jan 21. pii: thoraxjnl-2019-214014.
    PubMed    


    December 2019
  18. KHAKWANI A, Harden S, Beckett P, Baldwin D, et al
    Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.
    Thorax. 2019 Dec 26. pii: thoraxjnl-2018-212493.
    PubMed     Abstract available


    November 2019
  19. ZHANG Z, Zhu D, Cui B, Ding R, et al
    Association between particulate matter air pollution and lung cancer.
    Thorax. 2019 Nov 14. pii: thoraxjnl-2019-213722.
    PubMed     Abstract available


    September 2019
  20. RUPAREL M, Quaife SL, Dickson JL, Horst C, et al
    Evaluation of cardiovascular risk in a lung cancer screening cohort.
    Thorax. 2019 Sep 26. pii: thoraxjnl-2018-212812.
    PubMed     Abstract available


  21. FISK M, Bolton CE
    Is targeted lung cancer screening an opportune time to address cardiovascular risk?
    Thorax. 2019 Sep 26. pii: thoraxjnl-2019-213790.
    PubMed    


  22. BALATA H, Tonge J, Barber PV, Colligan D, et al
    Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.
    Thorax. 2019 Sep 3. pii: thoraxjnl-2018-212601.
    PubMed     Abstract available


    July 2019
  23. O'DOWD EL, Ten Haaf K
    Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results.
    Thorax. 2019 Jul 30. pii: thoraxjnl-2019-213156.
    PubMed    


    June 2019
  24. PEZZELLA F
    Early squamous cell lung carcinoma: prognostic biomarkers for the many.
    Thorax. 2019;74:527-528.
    PubMed    


  25. WINTER A, Aberle DR, Hsu W
    External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
    Thorax. 2019;74:551-563.
    PubMed     Abstract available


    May 2019
  26. STEINER MC
    Should pulmonary rehabilitation be a standard of care in lung cancer?
    Thorax. 2019 May 15. pii: thoraxjnl-2019-213157.
    PubMed    


  27. EDBROOKE L, Aranda S, Granger CL, McDonald CF, et al
    Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial.
    Thorax. 2019 May 2. pii: thoraxjnl-2018-212996.
    PubMed     Abstract available


  28. HORST C, Nair A, Janes SM
    Lessons on managing pulmonary nodules from NELSON: we have come a long way.
    Thorax. 2019;74:427-429.
    PubMed    


    April 2019
  29. BRIMS F, Gunatilake S, Lawrie I, Marshall L, et al
    Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial.
    Thorax. 2019;74:354-361.
    PubMed     Abstract available


  30. MARTINEZ-TERROBA E, Behrens C, Agorreta J, Monso E, et al
    5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
    Thorax. 2019;74:371-379.
    PubMed     Abstract available


    March 2019
  31. RAGHU VK, Zhao W, Pu J, Leader JK, et al
    Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Thorax. 2019 Mar 12. pii: thoraxjnl-2018-212638.
    PubMed     Abstract available


  32. ZHANG S, Zhang S, Zhang W, He J, et al
    Pulmonary inflammatory myofibroblastic tumour and IgG4-related disease presenting with lower limb paralysis.
    Thorax. 2019;74:313-314.
    PubMed    


    February 2019
  33. ROGERS TK
    Minimising diagnostic delay in lung cancer.
    Thorax. 2019 Feb 23. pii: thoraxjnl-2018-212927.
    PubMed    


  34. BARCLAY ME, Lyratzopoulos G, Walter FM, Jefferies S, et al
    Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.
    Thorax. 2019 Feb 18. pii: thoraxjnl-2018-212456.
    PubMed     Abstract available


  35. YONG PC, Sigel K, de-Torres JP, Mhango G, et al
    The effect of radiographic emphysema in assessing lung cancer risk.
    Thorax. 2019 Feb 5. pii: thoraxjnl-2018-212457.
    PubMed     Abstract available


  36. ZHANG J, Dong A, Cui Y, Wang Y, et al
    Diffuse cavitary benign metastasising leiomyoma of the lung.
    Thorax. 2019;74:208-209.
    PubMed    


  37. ONG P, Grosu HB, Debiane L, Casal RF, et al
    Long-term quality-adjusted survival following therapeutic bronchoscopy for malignant central airway obstruction.
    Thorax. 2019;74:141-156.
    PubMed     Abstract available


    January 2019
  38. ADIZIE JB, Khakwani A, Beckett P, Hubbard R, et al
    Impact of organisation and specialist service delivery on lung cancer outcomes.
    Thorax. 2019 Jan 19. pii: thoraxjnl-2018-212588.
    PubMed     Abstract available


  39. EMERY JD, Murray SR, Walter FM, Martin A, et al
    The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.
    Thorax. 2019 Jan 10. pii: thoraxjnl-2018-212506.
    PubMed     Abstract available


    December 2018
  40. WALTER JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, et al
    Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Thorax. 2018 Dec 27. pii: thoraxjnl-2018-212152.
    PubMed     Abstract available


    November 2018
  41. CROSBIE PA, Balata H, Evison M, Atack M, et al
    Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.
    Thorax. 2018 Nov 12. pii: thoraxjnl-2018-212547.
    PubMed     Abstract available


  42. METS OM, Schaefer-Prokop CM, de Jong PA
    Primary lung cancer in patients with previous malignancies: a nationwide study.
    Thorax. 2018 Nov 1. pii: thoraxjnl-2018-211891.
    PubMed     Abstract available


  43. VIS DC, Kelly MM, Lee AG, Gelfand G, et al
    Contralateral recurrence of inflammatory myofibroblastic tumour of the lung 10 years after pneumonectomy.
    Thorax. 2018;73:1089-1090.
    PubMed    


    October 2018
  44. POWELL HA
    Socioeconomic deprivation and inequalities in lung cancer: time to delve deeper?
    Thorax. 2018 Oct 31. pii: thoraxjnl-2018-212362.
    PubMed    


    August 2018
  45. BELOT A, Fowler H, Njagi EN, Luque-Fernandez MA, et al
    Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.
    Thorax. 2018 Aug 12. pii: thoraxjnl-2017-211395.
    PubMed     Abstract available


  46. PEAKE MD, Navani N, Baldwin DR
    The continuum of screening and early detection, awareness and faster diagnosis of lung cancer.
    Thorax. 2018 Aug 10. pii: thoraxjnl-2018-212189.
    PubMed    


    June 2018
  47. FIELD JK, Duffy SW
    Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?
    Thorax. 2018 Jun 28. pii: thoraxjnl-2018-211814.
    PubMed    


  48. KENNEDY MPT, Cheyne L, Darby M, Plant P, et al
    Lung cancer stage-shift following a symptom awareness campaign.
    Thorax. 2018 Jun 27. pii: thoraxjnl-2018-211842.
    PubMed     Abstract available


  49. KIM CH, Jeong JS, Kim SR, Lee YC, et al
    Endobronchial epithelial-myoepithelial carcinoma of the lung.
    Thorax. 2018;73:593-594.
    PubMed    


    May 2018
  50. CHUNG K, Mets OM, Gerke PK, Jacobs C, et al
    Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population.
    Thorax. 2018 May 18. pii: thoraxjnl-2017-211372.
    PubMed     Abstract available


    April 2018
  51. ATHEY VL, Walters SJ, Rogers TK
    Symptoms at lung cancer diagnosis are associated with major differences in prognosis.
    Thorax. 2018 Apr 17. pii: thoraxjnl-2018-211596.
    PubMed     Abstract available


  52. WALTER JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, et al
    Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Thorax. 2018 Apr 16. pii: thoraxjnl-2017-211376.
    PubMed     Abstract available


  53. XU KF, Tian X, Yang Y, Zhang H, et al
    Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage.
    Thorax. 2018;73:308-310.
    PubMed    


    March 2018
  54. SCHREUDER A, Schaefer-Prokop CM, Scholten ET, Jacobs C, et al
    Lung cancer risk to personalise annual and biennial follow-up computed tomography screening.
    Thorax. 2018 Mar 30. pii: thoraxjnl-2017-211107.
    PubMed     Abstract available


  55. MOLLER H, Coupland VH, Tataru D, Peake MD, et al
    Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.
    Thorax. 2018 Mar 6. pii: thoraxjnl-2017-210710.
    PubMed     Abstract available


  56. WOOLHOUSE I, Maskell NA
    Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.
    Thorax. 2018;73:210-212.
    PubMed    


  57. LI R, Li X, Xue R, Yang F, et al
    Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs).
    Thorax. 2018;73:290-292.
    PubMed    


    February 2018
  58. CROSBIE PA, Balata H, Evison M, Atack M, et al
    Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.
    Thorax. 2018 Feb 13. pii: thoraxjnl-2017-211377.
    PubMed     Abstract available


  59. TEN HAAF K, van der Aalst CM, de Koning HJ
    Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening.
    Thorax. 2018 Feb 9. pii: thoraxjnl-2017-211149.
    PubMed    


  60. BRUSTLE K, Zachariassen K, Vrugt B, Frauenfelder T, et al
    Acute pulmonary embolism and multiple pulmonary nodules mimicking metastatic disease.
    Thorax. 2018;73:193-194.
    PubMed    


    January 2018
  61. MA C, Frosch ZA, Overmoyer B, Cooper AZ, et al
    Vocal fold paralysis on positron emission tomography-CT.
    Thorax. 2018;73:97-98.
    PubMed    


  62. DANTAS GC, Shoji H, Hoelz C, Funari MBG, et al
    Herpes simplex lesion mimicking left upper lobe bronchial tumour.
    Thorax. 2018;73:94-95.
    PubMed    


    November 2017
  63. HJELMBORG J, Korhonen T, Holst K, Skytthe A, et al
    Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer.
    Thorax. 2017;72:1021-1027.
    PubMed     Abstract available


    October 2017
  64. LUCHTENBORG M, Morris EJA, Tataru D, Coupland VH, et al
    Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
    Thorax. 2017 Oct 27. pii: thoraxjnl-2017-210362.
    PubMed     Abstract available


  65. HEUVELMANS MA, Walter JE, Vliegenthart R, van Ooijen PMA, et al
    Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.
    Thorax. 2017 Oct 22. pii: thoraxjnl-2017-210770.
    PubMed     Abstract available


  66. KALE MS, Sigel K, Mhango G, Wisnivesky JP, et al
    Assessing the extent of non-aggressive cancer in clinically detected stage I non-small cell lung cancer.
    Thorax. 2017 Oct 20. pii: thoraxjnl-2017-210309.
    PubMed     Abstract available


    September 2017
  67. SAITOH Y, Ohnishi-Amemiya A, Asano M, Tanaka Y, et al
    Unique radiological features of two cases of primary pulmonary diffuse large B-cell lymphoma.
    Thorax. 2017;72:859-860.
    PubMed    


    August 2017
  68. MENGOLI MC, Rossi G, Tiseo M, Barbieri F, et al
    'Turban-like' skull metastasis from pulmonary adenocarcinoma.
    Thorax. 2017;72:767-768.
    PubMed    


    July 2017
  69. LOCOCO F, Cardillo G, Veronesi G
    Does a lung cancer screening programme promote smoking cessation?
    Thorax. 2017 Jul 26. pii: thoraxjnl-2017-210621.
    PubMed    


  70. CALLISTER ME, Janes SM
    Defining the path: lung cancer CT screening in Europe.
    Thorax. 2017 Jul 19. pii: thoraxjnl-2017-210268.
    PubMed    


  71. BRAIN K, Carter B, Lifford KJ, Burke O, et al
    Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
    Thorax. 2017 Jul 14. pii: thoraxjnl-2016-209690.
    PubMed     Abstract available


  72. WATSON N
    Radiation exposure during lung cancer diagnostic work-up: how important in the wider picture?
    Thorax. 2017 Jul 5. pii: thoraxjnl-2017-210360.
    PubMed    


    April 2017
  73. RINTOUL RC, Atherton R, Tweed K, Yates S, et al
    Exposure of patients to ionising radiation during lung cancer diagnostic work-up.
    Thorax. 2017 Apr 25. pii: thoraxjnl-2016-209641.
    PubMed     Abstract available


  74. PACI E, Puliti D, Lopes Pegna A, Carrozzi L, et al
    Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Thorax. 2017 Apr 4. pii: thoraxjnl-2016-209825.
    PubMed     Abstract available


    March 2017
  75. YOUSAF-KHAN U, van der Aalst C, de Jong PA, Heuvelmans M, et al
    Risk stratification based on screening history: the NELSON lung cancer screening study.
    Thorax. 2017 Mar 30. pii: thoraxjnl-2016-209892.
    PubMed     Abstract available


  76. MARSHALL HM, Zhao H, Bowman RV, Passmore LH, et al
    The effect of different radiological models on diagnostic accuracy and lung cancer screening performance.
    Thorax. 2017 Mar 22. pii: thoraxjnl-2016-209624.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: